Genocea Biosciences

-$0.0005 (-2.89%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch GNCA and buy or sell other stocks, options, and ETFs commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.

CEO
William D. Clark
Employees
74
Headquarters
Cambridge, Massachusetts
Founded
2006

GNCA Key Statistics

Market cap
987.56K
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.30M
High today
$0.0173
Low today
$0.0154
Open price
$0.0165
Volume
266.75K
52 Week high
$2.41
52 Week low
$0.012
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure